ORCHESTRATING THE IMMUNE SYSTEM TO MAXIMIZE IMMUNITY

  ADDRESSING GLOBAL HEALTH PROBLEMS

Prime Vector Technologies is an innovative research company designing vaccines based on an exceptional viral vector. Using the Orf virus, we have developed a proprietary platform technology for the generation of potent, polyvalent, preventive as well as therapeutic vaccines against infectious diseases and cancer for both, humans and animals.

Modular Brick System

Our technology allows the fast and flexible insertion and combination of several different antigens and immunomodulatory elements for improved immunogenicity.

Superior T-Cell Response

Our ORF virus based vaccines elicit very strong antigen-specific humoral as well as cellular immune responses and show superiority in external benchmarks.

Rapid Vaccine Generation

Although technologies for the prevention or therapy of diseases are advancing, mortality rates are likely increasing. PRIME ensures the fast generation of efficient vaccines.

Natural Compatibility

There is no prevalence of the ORF virus in the human population and no occurence of neutralizing antibodies against the vector backbone allowing repeated immunizations.

STRIVING TO IMPROVE LIVES OF HUMANS AND ANIMALS

Our mission is to provide the human and veterinary health system with tailored, safe and reliable vaccines for preventive and therapeutic application against infectious diseases and cancer. For that, we rely on our innovative and highly effective vaccine platform that is based on an advanced level of virology and immunology research.

In order to reach our goals, we're looking for partners!